Notice2022-23609

Bulk Manufacturer of Controlled Substances Application: Nanosyn Inc.

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
October 31, 2022

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Nanoysn Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 209 (Monday, October 31, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Page 65608]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-23609]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1107]


Bulk Manufacturer of Controlled Substances Application: Nanosyn 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Nanoysn Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
December 30, 2022. Such persons may also file a written request for a 
hearing on the application on or before December 30, 2022.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 2, 2022, Nanosyn Inc., 3331 Industrial 
Drive, Suite B, Santa Rosa, California 95403-2062, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Oxymorphone............................     9652  II
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company is a contract manufacturer. At the request of the 
company's customers, it manufactures derivatives of the above 
controlled substances in bulk form. No other activities for these drug 
codes are authorized for this registration.

Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-23609 Filed 10-28-22; 8:45 am]
BILLING CODE 4410-09-P


</pre></body>
</html>
Indexed from Federal Register on October 31, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.